$9.34 -0.06 (-0.64%)
11/24/2009 4:00 PM

Seattle Genetics, Inc. (SGEN)

CAPS Rating: 4 out of 5

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases.

Featured Broker Partners